Title : Galantamine improves enhanced impulsivity, impairments of attention and long-term potentiation induced by prenatal nicotine exposure to mice.

Pub. Date : 2020 Oct

PMID : 32652142






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Systemic treatment with GAL (1 mg/kg, s.c.), an allosteric potentiating ligand for the nicotinic acetylcholine receptor (nAChR) and a weak cholinesterase inhibitor, attenuated the enhancement of impulsivity and impairment of attention induced by PNE in mice. Galantamine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus
2 Systemic treatment with GAL (1 mg/kg, s.c.), an allosteric potentiating ligand for the nicotinic acetylcholine receptor (nAChR) and a weak cholinesterase inhibitor, attenuated the enhancement of impulsivity and impairment of attention induced by PNE in mice. Galantamine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus
3 The effects of GAL were blocked by an alpha 7 nAChR antagonist, methyllycaconitine (1 mg/kg, i.p.). Galantamine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus